FIELD: medicine.
SUBSTANCE: therapeutic agent containing an activated-potentiated form of antibodies to the brain-specific S-100 protein, and an activated-potentiated form of antibodies to endothelial NO-synthase as an additional exalting component is administered.
EFFECT: effective treatment of Alzheimer's disease by the synergetic action of the components.
11 cl, 5 tbl, 3 ex
Authors
Dates
2014-12-20—Published
2011-07-01—Filed